A cannabis legalization campaign in Ohio has managed to attract enough signatures to qualify for review by the state’s legislature. The proposed bill, which prompts legislators to regulate adult-use (recreational) cannabis in the same way as alcohol, must now be considered by legislative members before undergoing a ballot vote in November.
The Coalition to Regulate Marijuana Like Alcohol (CRMLA) issued an official news release on the subject. As per the release, the secretary of state told members of the campaign on Friday, Jan. 28 that Ohio’s cannabis legalization initiative had gained an adequate number of signatures to forcibly stimulate contemplation by lawmakers.
Should lawmakers amend the state constitution in accordance with the bill’s suggestions, adult-use cannabis sales would be legalized across Ohio, which is home to nearly 12 million people.
As per the CRMLA’s proposed law to legalize and regulate the cultivation, manufacturing, testing, and sale of cannabis for people aged 21 and up, the measure “fixes a broken system.” Back in December 2021, the group took its first stab at legalization. However, to the dismay of CRMLA members, 206,943 submitted signatures was not sufficient to have the bill considered by lawmakers.
Hope prevailed and the campaign took advantage of a second opportunity to gather and submit an extra 29,918 signatures. Moving forwards, a four-month wait will determine whether or not state lawmakers choose to enact CRMLA’s proposal for legal adult-use cannabis in Ohio, shoot it down, or simply turn a blind eye to it.
Should the legislature fail to adopt the measure, an additional 132,877 signatures would need to be collected from voters. A successful signature-gathering process would see the CRMLA’s recreational cannabis legalization initiative receive a vote on the November general election ballot.
Fortunately, if that scenario transpires, CRMLA Director Tom Haren affirms that campaign members will be “fully prepared to do” what it takes to get recreational cannabis legalized in Ohio.
On Wednesday, Feb. 9, Senate President Matt Huffman—who is considered to be one of the most influential political members in the state—turned his nose up at Ohio’s recreational marijuana initiative. During a discussion with reporters, the Lima Republican said that he would not contribute to a legal market transpiring.
“I don’t want anybody to misunderstand my position,” Huffman told reporters. “I’m not going to bring it to the Senate floor. And if that means people want to go put it on the ballot, have at it.”
According to the House Majority Leader, the chances of a recreational cannabis bill being successfully voted on by Ohio lawmakers is highly unlikely. Plus, even if it did, Gov. Mike DeWine (R) has hinted that he would veto it. Such a threat, combined with legislative resistance, means that Ohio’s adult-use cannabis legalization campaign faces an uphill battle if it is to trigger an amendment to the state constitution.
With that being said, a signature drive would probably be the campaign’s only road to success. In that case, the CRMLA would be required to, once again, submit the signatures 125 days prior to the Nov. 8 election day launch—July 6.
Almost $1.1 million was spent by the coalition during the initial signature-gathering round for cannabis legalization in Ohio, based on a report published by the coalition. Of that amount, the bulk (around $1 million) was earmarked for Texas-headquartered ballot referendum specialist firm Advanced Micro Targeting.
Marijuana Policy Project (MPP), a national cannabis lobbyist group, recently revealed disclosures that were filed with the secretary of state’s office. The disclosures indicate that the coalition was financially supported to the amount of approximately $700,000. An additional $600,000 was awarded by a handful of licensed medical cannabis businesses.
Cannabis currently remains illegal for recreational purposes in Ohio, where plant possession not exceeding 100 grams (equivalent to 3.5 ounces) has been decriminalized since the year 1975. Since this time, numerous cities spread across the state have proceeded to expand on their reform efforts.
Perhaps the biggest change occurred in 2016 when cannabis in Ohio was legalized for medical purposes. House Bill 523 was signed by Gov. John Kasich on June 8, 2016. The measure allowed Ohioans to legally travel with medical cannabis across state lines within three months of the bill being approved by the state legislature.
Examples of some medical conditions that are featured on the eligibility criteria for medical cannabis in Ohio include AIDS, ALS, Alzheimer’s disease, cancer, chronic pain, CTE, Crohn’s, fibromyalgia, glaucoma, hepatitis C, IBS, sickle cell anemia, spinal cord disease, seizures, Tourette’s syndrome, traumatic brain injury, ulcerative colitis, Parkinson’s disease, and PTSD.
According to research, “Migraine is highly prevalent, affecting 12% of the population, attacking up to 17% of women and 6% of men yearly. Among children, it tends to happen more in girls than boys.” A migraine can be very disabling and last from hours to two or three days. Migraines are considered to be the…
PTSD can have far-reaching effects on health, functionality as well as on quality of living, which is why having access to effective treatment is so important. If you are living with PTSD or are living with someone who has PTSD, you would have first-hand experience with how challenging it can be getting through life on…
Up until recently, lack of cannabis education meant that people were blissfully unaware of the fact that the plant is not limited to just one strain and, therefore, does not produce just one type of effect. Fortunately, agricultural experimentation has led to the market exploding in terms of strains that can satisfy everyone, from beginners…
Using cannabis to help combat anxiety is a tricky business. Studies have given us significant evidence that cannabis can be used to help cope with anxiety and because anxiety is so common, that’s an extremely welcome piece of information. In fact, 72% of daily cannabis users reported consumption to relax or relieve tension and 58%…
A cannabis compound that has been described as “cutting-edge” and “so elusive, laboratories often misidentify the compound as CBC (cannabichromene) or CBL (cannabicyclol)” is finally becoming better understood. Delta-10-tetrahydrocannabinol (delta-10 THC) is a need-to-know cannabinoid, and here’s why. What Is Delta-10 THC? Does Delta-10 Get You High? Is Delta-10 Safe? How Is Delta-10 Created? Is…
The anti-nausea and vomiting effects of cannabis have been known for several centuries. The evidence eventually became so compelling in clinical trials…
Experts are taking a bird’s eye view of an exciting and rapidly evolving area in cannabis research known as the endocannabinoidome (eCBome)….
Spliffs and joints, while similar, are different cannabis products rolled up in paper. If you are a seasoned cannabis smoker, you’re probably…